Increasing HPV Vaccination Rates Via Educational Interventions in Schools Located Within Cedars-Sinai Catchment Areas
NCT03953911 · Status: UNKNOWN · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 3
Last updated 2019-05-17
Summary
Infections with human papillomavirus (HPV) can cause cancer of the cervix, vagina, anus, throat, mouth, and penis. Prevention of these HPV-related cancers could be achieved by immunization with the nonavalent (HPV6,11,16,18,31,33,45,52,58) vaccine currently commercially available. However, in the U.S. approximately only 30% of females and 20% of males in the recommended age group receive the complete, three-dose HPV vaccine. Furthermore, data from the Los Angeles county suggest that HPV vaccination rates among these groups are lower than the national average. Significant barriers clearly remain including knowledge of the vaccine, transportation, number of doses and concern of side effects. Several programs worldwide have shown that schools remain an important venue for education as well as vaccination. In the US, vaccination within schools remains difficult because of many barriers including lack of nursing, insurance reimbursement, and liability. However, the school remains an important access to educational formats. The objective of this study is to evaluate the effectiveness of educational sessions on the HPV vaccine among parents with children of vaccination age as a strategy to increase HPV vaccine uptake, by comparing HPV vaccination rates before and after the intervention. It is hypothesized HPV vaccine uptake will improve through the receipt of educational sessions to the parents of middle school children about the importance of the anti-cancer vaccine, the HPV vaccine. Three schools within Cedars-Sinai catchment area with whom Cedars-Sinai already has a Memorandum of Understanding in place: Berendo, Drew, and Carver Middle Schools in Los Angeles (SPA 4, SPA 6) will be recruited to the study. HPV vaccination rates will be compared before and after the intervention at the end of the observation period (12 months).
Conditions
- Human Papilloma Virus
- HPV Vaccination
- Health Education
Interventions
- BIOLOGICAL
-
Mobile Clinic
This intervention involves the availability of a free mobile clinic operated by Cedar-Sinai Medical Center providing free HPV vaccinations at school campuses.
- BEHAVIORAL
-
Educational Sessions for Parents
This intervention involves providing free weekly educational sessions for parents of students at the participant schools pertaining to the HPV Vaccination.
Sponsors & Collaborators
-
University of California, Los Angeles
collaborator OTHER -
Cedars-Sinai Medical Center
lead OTHER
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- PREVENTION
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 11 Years
- Max Age
- 13 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2019-05-28
- Primary Completion
- 2020-05-27
- Completion
- 2020-06-30
More Related Trials
-
Prevention of HPV in the School Health Service
NCT02280967 ·Status: COMPLETED ·Phase: NA
-
A Tailored, Health Communication Intervention for HPV Vaccine Hesitant Families
NCT04380623 ·Status: UNKNOWN ·Phase: NA
-
Educate and Improve Underserved Populations' Uptake and Completion of the HPV Vaccine
NCT04611022 ·Status: RECRUITING ·Phase: NA
-
An Information-Motivation-Behavioral Skills (IMB) Intervention to Promote Human Papillomavirus Vaccination Among Women
NCT02464358 ·Status: COMPLETED ·Phase: NA
-
Marketability of a Technology-based Intervention to Increase HPV Vaccination
NCT03497936 ·Status: COMPLETED ·Phase: NA
-
Increasing HPV Vaccination in Community-Based Pediatric Practices
NCT03399396 ·Status: COMPLETED ·Phase: NA
-
Engaging College Students in Developing and Testing a Video-based Intervention for HPV Vaccination Promotion
NCT06397378 ·Status: RECRUITING ·Phase: NA
-
Educational Video's Impact on Knowledge Regarding Cervical Cancer Screening
NCT05756192 ·Status: COMPLETED ·Phase: NA
-
An HPV Vaccine Provider Intervention in Safety Net Clinics
NCT02808832 ·Status: COMPLETED ·Phase: NA
-
Adaptation Of An HPV Education Resource To Promote HPV Vaccination
NCT04974619 ·Status: COMPLETED
-
Impact of HPV Vaccine On The Prevalence Of HPV In Norway
NCT02934724 ·Status: COMPLETED
-
Knowledge and Attitudes Towards Human Papillomavirus Infections and HPV Vaccination
NCT03888599 ·Status: COMPLETED
-
Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Human Papillomavirus (HPV) Vaccine (GSK580299) in Healthy Female Subjects 10-25 Years of Age.
NCT00481767 ·Status: COMPLETED ·Phase: PHASE3
-
Effectiveness of HPV Vaccine in Thai Adult Women
NCT03763565 ·Status: COMPLETED
-
Men and Women Offering Understanding of Throat HPV
NCT03644563 ·Status: ACTIVE_NOT_RECRUITING
-
Multimodality Treatments of HPV-related Lesions of the Female Genital Tract
NCT05938192 ·Status: RECRUITING
-
The Role of Cyberchondria Severity in the Relationship Between HPV Awareness and Vaccination Attitudes in Adult Women
NCT06800456 ·Status: COMPLETED
-
Vaccine Therapy in Treating Patients With Advanced or Recurrent Cancer
NCT00019110 ·Status: COMPLETED ·Phase: PHASE1
-
Making Effective Human Papillomavirus (HPV) Vaccine Recommendations
NCT02377843 ·Status: COMPLETED ·Phase: NA
-
Acceptability of Human Papillomavirus (HPV) Self-sampling Tools for Cervical Cancer Prevention
NCT03613493 ·Status: TERMINATED ·Phase: NA
-
Impact of HPV Education on Knowledge, Awareness, and Concern
NCT07110909 ·Status: COMPLETED ·Phase: NA
-
Prevention and Control of Neoplasms Associated With HPV in High-risk Groups in Mexico City: The Condesa Study
NCT05149248 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Human Papillomavirus (HPV) Vaccination Among Survivors of Childhood Cancer
NCT01117389 ·Status: COMPLETED
-
A Multicenter Cohort Study Assessing the Efficacy and Adverse Effects of HPV Vaccination in Chinese Women
NCT05932576 ·Status: UNKNOWN
-
Faster Elimination of HPV Infection and Cervical Cancer Using Concomitant HPV Vaccination and HPV Screening: A Demonstration Project in Rwanda
NCT06536855 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4